| Are consumers ready to take part in the Pharmacovigilance System?—A Portuguese preliminary study concerning ADR reporting C Matos, F van Hunsel, J Joaquim European journal of clinical pharmacology 71, 883-890, 2015 | 53 | 2015 |
| Patient reporting of adverse drug reactions: an international survey of national competent authorities’ views and needs C Matos, L Härmark, F van Hunsel Drug safety 39, 1105-1116, 2016 | 45 | 2016 |
| The role of European patient organizations in pharmacovigilance C Matos, G Weits, F van Hunsel Drug Safety 42, 547-557, 2019 | 15 | 2019 |
| Patient organizations’ barriers in pharmacovigilance and strategies to stimulate their participation K Chinchilla, C Matos, V Hall, F van Hunsel Drug Safety 44, 181-191, 2021 | 14 | 2021 |
| Drug-induced sexual dysfunction: an analysis of reports to a national pharmacovigilance database C Valeiro, C Matos, J Scholl, F van Hunsel Drug Safety 45 (6), 639-650, 2022 | 12 | 2022 |
| Factors contributing to best practices for patient involvement in pharmacovigilance in Europe: a stakeholder analysis M van Hoof, K Chinchilla, L Härmark, C Matos, P Inácio, F van Hunsel Drug Safety 45 (10), 1083-1098, 2022 | 11 | 2022 |
| Inappropriate prescriptions in older people—translation and adaptation to Portuguese of the STOPP/START screening tool L Monteiro, M Monteiro-Soares, C Matos, I Ribeiro-Vaz, A Teixeira, ... International Journal of Environmental Research and Public Health 19 (11), 6896, 2022 | 9 | 2022 |
| Attitudes and opinions of Portuguese community pharmacy professionals towards patient reporting of adverse drug reactions and the pharmacovigilance system C Matos, L Rodrigues, J Joaquim Drugs & Therapy Perspectives 33, 188-194, 2017 | 8 | 2017 |
| Diabetes patient’s pharmacovigilance knowledge and risk perception: the influence of being part of a patient organisation C Matos, F van Hunsel, R Tavares Ribeiro, D Nascimento do Ó, ... Therapeutic Advances in Drug Safety 11, 2042098620953935, 2020 | 7 | 2020 |
| Attitudes and knowledge of community pharmacy professionals regarding the spontaneous reporting of adverse drug reactions: a preliminary study in Coimbra, Portugal C Matos, J Joaquim, T Pires Drugs & Therapy Perspectives 33, 88-94, 2017 | 6 | 2017 |
| Potential risks of acrylamide for humans–review A Baltazar, JJ Joaquim, C Matos Clinical Therapeutics 39 (8), e93, 2017 | 4 | 2017 |
| Adverse drug reactions to opioids: a study in a national pharmacovigilance database M Gustafsson, C Matos, J Joaquim, J Scholl, F van Hunsel Drug Safety 46 (11), 1133-1148, 2023 | 3 | 2023 |
| Knowledge and consumption of emergency contraception pills in a tertiary education student population J Joaquim, M Reis, C Matos, J Lopes, T Pires Drugs & Therapy Perspectives 34, 583-589, 2018 | 3 | 2018 |
| The use of probiotics and the effect in antibiotic associated diarrhea A Andrade, C Matos, J Lopes, T Pires, J Joaquim Clinical Therapeutics 39 (8), e47, 2017 | 3 | 2017 |
| All-round approaches to increase adverse drug reaction reports: a scoping review J Joaquim, C Matos, D Guerra, R Mateos-Campos Drugs & Therapy Perspectives 39 (7), 249-261, 2023 | 2 | 2023 |
| Active involvement of the general public in pharmacovigilance CF Romao Matos | 2 | 2020 |
| Medication errors in Community Pharmacy: Potencial Causes and strategies for Prevention J Lopes, J Joaquim, C Matos, T Pires Clinical Therapeutics 37 (8), e119, 2015 | 2 | 2015 |
| Are Patients Ready to Take Part in the Pharmacovigilance System-A Portuguese Preliminary Study Concerning Drug Reaction Reporting CF Matos, FP van Hunsel, JJ Joaquim PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 23, 293-293, 2014 | 2 | 2014 |
| Attitudes and knowledge of community pharmacy professionals to adverse drug reaction reporting in Coimbra, Portugal CF Matos, JJ Joaquim, TS Pires DRUG SAFETY 34 (10), 1006-1007, 2011 | 2 | 2011 |
| Implementation and impact of integrated health and social care services: an umbrella review RC de Matos, G do Nascimento, AC Fernandes, C Matos Journal of Public Health Policy 45 (1), 14-29, 2024 | 1 | 2024 |
